Skip to main content
. 2016 Jan 12;20(3):518–525. doi: 10.1111/jcmm.12736

Figure 5.

Figure 5

Inactivation of RUNX3 promotes glioma tumourigenic. Expression of RUNX3 in normal tissues and GB tissues from WHO stage I to IV (WHO standard).